Cancer stem cells and EMT in carcinoma

Cancer and Metastasis Reviews

Volumn 31, Issue 1-2, 2012, Pages 285-293

  Biddle, Adrian ^a   Mackenzie, Ian C ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cancer; CSC; EMT; MET; Stem

Indexed keywords

BETA CATENIN; CD24 ANTIGEN; CISPLATIN; DOXORUBICIN; HERMES ANTIGEN; MICRORNA 200; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; SALINOMYCIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT STEM CELL; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INVASION; CANCER PROGNOSIS; CANCER RELAPSE; CANCER STEM CELL; CARCINOMA; CELL ASSAY; CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; CELL RENEWAL; CELLULAR IMMUNITY; COLORECTAL CANCER; EPITHELIAL MESENCHYMAL TRANSITION; FATALITY; FLOW CYTOMETRY; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; LABORATORY; LIVER CELL CARCINOMA; METASTASIS; MOUTH SQUAMOUS CELL CARCINOMA; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; STROMA; T LYMPHOCYTE; TUMOR ESCAPE; TUMOR GROWTH; TUMOR RECURRENCE;

EID: 84862317685     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-012-9345-0     Document Type: Review

References (69)

1. Mani, S. A., Guo, W., Liao, M. J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., et al. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133(4), 704-715. doi:10.1016/j.cell.2008.03.027. (Pubitemid 351636299)
2. Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., & Kirchner, T. (2005). Opinion: Migrating cancer stem cells - An integrated concept of malignant tumour progression. Nature Reviews. Cancer, 5 (9), 744-749. doi:10.1038/nrc1694. (Pubitemid 41486367)
3. Biddle, A., Liang, X., Gammon, L., Fazil, B., Harper, L. J., Emich, H., et al. (2011). Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative. Cancer Research. doi:10.1158/0008-5472.CAN-11-1059.
4. Chaffer, C. L., Brennan, J. P., Slavin, J. L., Blick, T., Thompson, E. W., & Williams, E. D. (2006). Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: Role of fibroblast growth factor receptor-2. Cancer Research, 66(23), 11271-11278. doi:10.1158/0008-5472.CAN-06- 2044. (Pubitemid 46009956)
5. Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., et al. (2009). Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell, 138(4), 645-659. doi:10.1016/j.cell.2009.06.034.
6. Wang, Z., Li, Y., Ahmad, A., Azmi, A. S., Kong, D., Banerjee, S., et al. (2010). Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance. Drug Resistance Updates, 13(4-5), 109-118. doi:10.1016/j.drup.2010.07.001.
7. Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H., Jones, D. L., et al. (2006). Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Research, 66(19), 9339-9344. doi:10.1158/0008-5472.CAN-06-3126.
8. Gu, G., Yuan, J., Wills, M., & Kasper, S. (2007). Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Research, 67(10), 4807-4815. doi:10.1158/0008-5472.CAN-06-4608. (Pubitemid 46910189)
9. Mackenzie, I. C. (2008). Cancer stem cells. Annals of Oncology, 19(Suppl 5), v40-v43. doi:10.1093/annonc/mdn306.
10. Mackenzie, I. C. (2006). Stem cell properties and epithelial malignancies. European Journal of Cancer, 42(9), 1204-1212. doi:10.1016/j.ejca. 2006.01.041.
11. Morgan, J. E., & Partridge, T. A. (2003). Muscle satellite cells. The International Journal of Biochemistry & Cell Biology, 35(8), 1151-1156. (Pubitemid 36577304)
12. Stingl, J. (2009). Detection and analysis of mammary gland stem cells. The Journal of Pathology, 217(2), 229-241. doi:10.1002/path.2457.
13. Battula, V. L., Evans, K. W., Hollier, B. G., Shi, Y., Marini, F. C., Ayyanan, A., et al. (2010). Epithelial-mesenchymal transitionderived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem Cells, 28(8), 1435-1445. doi:10.1002/stem.467.
14. Bonnet, D., & Dick, J. E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine, 3(7), 730-737. (Pubitemid 27298715)
15. Singh, S. K., Clarke, I. D., Terasaki, M., Bonn, V. E., Hawkins, C., Squire, J., et al. (2003). Identification of a cancer stem cell in human brain tumors. Cancer Research, 63(18), 5821-5828. (Pubitemid 37187480)
16. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 100(7), 3983-3988. doi:10.1073/pnas.0530291100. (Pubitemid 36418143)
17. Locke, M., Heywood, M., Fawell, S., & Mackenzie, I. C. (2005). Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Research, 65(19), 8944-8950. doi:10.1158/0008-5472.CAN-05-0931. (Pubitemid 41377385)
18. Prince, M. E., Sivanandan, R., Kaczorowski, A., Wolf, G. T., Kaplan, M. J., Dalerba, P., et al. (2007). Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proceedings of the National Academy of Sciences of the United States of America, 104(3), 973-978. doi:10.1073/pnas.0610117104. (Pubitemid 46154721)
19. Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., et al. (2007). Identification of pancreatic cancer stem cells. Cancer Research, 67(3), 1030-1037. doi:10.1158/0008-5472.CAN-06-2030.
20. Patrawala, L., Calhoun, T., Schneider-Broussard, R., Li, H., Bhatia, B., Tang, S., et al. (2006). Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene, 25(12), 1696-1708. doi:10.1038/sj.onc.1209327.
21. Clay, M. R., Tabor, M., Owen, J. H., Carey, T. E., Bradford, C. R., Wolf, G. T., et al. (2010). Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head & Neck, 32(9), 1195-1201. doi:10.1002/hed.21315.
22. Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., et al. (2007). ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell, 1(5), 555-567. doi:10.1016/j.stem.2007.08.014. (Pubitemid 350056407)
23. Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne, C. K., Wu, M. F., et al. (2008). Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. Journal of the National Cancer Institute, 100(9), 672-679. doi:10.1093/jnci/djn123.
24. Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., et al. (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 444 (7120), 756-760. doi:10.1038/nature05236. (Pubitemid 44949604)
25. Singh, A., & Settleman, J. (2010). EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer. Oncogene, 29(34), 4741-4751. doi:10.1038/onc.2010.215.
26. Charafe-Jauffret, E., Ginestier, C., Iovino, F., Tarpin, C., Diebel, M., Esterni, B., et al. (2010). Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clinical Cancer Research, 16(1), 45-55. doi:10.1158/1078-0432.CCR-09-1630.
27. Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J.W., Guba, M., et al. (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell, 1(3), 313-323. doi:10.1016/j.stem.2007.06.002. (Pubitemid 47355323)
28. Hay, E. D. (2005). The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Developmental Dynamics, 233(3), 706-720. doi:10.1002/dvdy.20345.
29. Savagner, P., Kusewitt, D. F., Carver, E. A., Magnino, F., Choi, C., Gridley, T., et al. (2005). Developmental transcription factor slug is required for effective re-epithelialization by adult keratinocytes. Journal of Cellular Physiology, 202(3), 858-866. doi:10.1002/jcp.20188. (Pubitemid 40175863)
30. Kalluri, R., & Weinberg, R. A. (2009). The basics of epithelialmesenchymal transition. The Journal of Clinical Investigation, 119 (6), 1420-1428. doi:10.1172/JCI39104.
31. Wu, Y., Deng, J., Rychahou, P. G., Qiu, S., Evers, B. M., & Zhou, B. P. (2009). Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell, 15 (5), 416-428. doi:10.1016/j.ccr.2009.03.016.
32. Yang, M. H., Wu, M. Z., Chiou, S. H., Chen, P. M., Chang, S. Y., Liu, C. J., et al. (2008). Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nature Cell Biology, 10(3), 295-305. doi:10.1038/ncb1691.
33. Gjerdrum, C., Tiron, C., Hoiby, T., Stefansson, I., Haugen, H., Sandal, T., et al. (2010). Axl is an essential epithelial-tomesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proceedings of the National Academy of Sciences of the United States of America, 107(3), 1124-1129. doi:10.1073/pnas.0909333107.
34. Skvortsova, I., Skvortsov, S., Raju, U., Stasyk, T., Riesterer, O., Schottdorf, E. M., et al. (2010). Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximabinduced enhancement of squamous cell carcinoma radioresponse. Radiotherapy and Oncology, 96(1), 108-115. doi:10.1016/j.radonc.2010.04.017.
35. Bandyopadhyay, A., Wang, L., Agyin, J., Tang, Y., Lin, S., Yeh, I. T., et al. (2010). Doxorubicin in combination with a small TGFbeta inhibitor: A potential novel therapy for metastatic breast cancer in mouse models. PLoS One, 5(4), e10365. doi:10.1371/journal.pone.0010365.
36. Fuchs, B. C., Fujii, T., Dorfman, J. D., Goodwin, J. M., Zhu, A. X., Lanuti, M., et al. (2008). Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Research, 68(7), 2391-2399. doi:10.1158/0008-5472.CAN-07-2460. (Pubitemid 351521814)
37. Kudo-Saito, C., Shirako, H., Takeuchi, T., & Kawakami, Y. (2009). Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell, 15 (3), 195-206. doi:10.1016/j.ccr.2009.01. 023.
38. Shin, S. Y., Rath, O., Zebisch, A., Choo, S. M., Kolch, W., & Cho, K. H. (2010). Functional roles of multiple feedback loops in extracellular signal-regulated kinase and wnt signaling pathways that regulate epithelial-mesenchymal transition. Cancer Research, 70(17), 6715-6724. doi:10.1158/0008-5472.CAN-10-1377.
39. Smith, G. R., & Missailidis, S. (2004). Cancer, inflammation and the AT1 and AT2 receptors. Journal of Inflammation (London), 1 (1), 3. doi:10.1186/1476-9255-1-3.
40. Chang, H. Y., Nuyten, D. S., Sneddon, J. B., Hastie, T., Tibshirani, R., Sorlie, T., et al. (2005). Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proceedings of the National Academy of Sciences of the United States of America, 102(10), 3738-3743. doi:10.1073/pnas.0409462102. (Pubitemid 40354681)
41. Thiery, J. P. (2003). Epithelial-mesenchymal transitions in development and pathologies. Current Opinion in Cell Biology, 15(6), 740-746.
42. Wellner, U., Schubert, J., Burk, U. C., Schmalhofer, O., Zhu, F., Sonntag, A., et al. (2009). The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nature Cell Biology, 11(12), 1487-1495. doi:10.1038/ncb1998.
43. Barrandon, Y., & Green, H. (1987). Three clonal types of keratinocyte with different capacities for multiplication. Proceedings of the National Academy of Sciences of the United States of America, 84(8), 2302-2306. (Pubitemid 17075859)
44. Harper, L. J., Piper, K., Common, J., Fortune, F., & Mackenzie, I. C. (2007). Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma. Journal of Oral Pathology& Medicine, 36 (10), 594-603. doi:10.1111/j.1600-0714.2007.00617.x. (Pubitemid 47609813)
45. Li, H., Chen, X., Calhoun-Davis, T., Claypool, K., & Tang, D. G. (2008). PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Research, 68(6), 1820-1825. doi:10.1158/0008- 5472.CAN-07-5878. (Pubitemid 351416567)
46. Keller, P. J., Lin, A. F., Arendt, L. M., Klebba, I., Jones, A. D., Rudnick, J. A., et al. (2010). Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines. Breast Cancer Research, 12(5), R87. doi:10.1186/bcr2755.
47. Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., Spaderna, S., et al. (2008). A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Reports, 9(6), 582-589. doi:10.1038/ embor.2008.74.
48. Chaffer, C. L., Brueckmann, I., Scheel, C., Kaestli, A. J., Wiggins, P. A., Rodrigues, L. O., et al. (2011). Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proceedings of the National Academy of Sciences of the United States of America, 108(19), 7950-7955. doi:10.1073/pnas.1102454108.
49. Gaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J. F., Harrington, K., et al. (2007). Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nature Cell Biology, 9(12), 1392-1400. doi:10.1038/ncb1658. (Pubitemid 350201752)
50. Giampieri, S., Manning, C., Hooper, S., Jones, L., Hill, C. S., & Sahai, E. (2009). Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nature Cell Biology, 11(11), 1287-1296. doi:10.1038/ncb1973.
51. Asiedu, M. K., Ingle, J. N., Behrens, M. D., Radisky, D. C., & Knutson, K. L. (2011). TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype. Cancer Research, 71(13), 4707-4719. doi:10.1158/0008-5472.CAN-10-4554.
52. Korpal, M., Ell, B. J., Buffa, F. M., Ibrahim, T., Blanco, M. A., Celia-Terrassa, T., et al. (2011). Direct targeting of Sec23a by miR- 200 s influences cancer cell secretome and promotes metastatic colonization. Nature Medicine, 17(9), 1101-1108. doi:10.1038/nm.2401.
53. Korpal, M., Lee, E. S., Hu, G., & Kang, Y. (2008). The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. Journal of Biological Chemistry, 283(22), 14910-14914. doi:10.1074/jbc.C800074200.
54. Olumi, A. F., Grossfeld, G. D., Hayward, S. W., Carroll, P. R., Tlsty, T. D., & Cunha, G. R. (1999). Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Research, 59(19), 5002-5011. (Pubitemid 29472907)
55. Kojima, Y., Acar, A., Eaton, E. N., Mellody, K. T., Scheel, C., Ben-Porath, I., et al. (2010). Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumorpromoting mammary stromal myofibroblasts. Proceedings of the National Academy of Sciences of the United States of America, 107 (46), 20009-20014. doi:10.1073/pnas.1013805107.
56. Lopez-Novoa, J. M., & Nieto, M. A. (2009). Inflammation and EMT: An alliance towards organ fibrosis and cancer progression. EMBO Molecular Medicine, 1(6-7), 303-314. doi:10.1002/emmm.200900043.
57. Creighton, C. J., Li, X., Landis, M., Dixon, J. M., Neumeister, V. M., Sjolund, A., et al. (2009). Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proceedings of the National Academy of Sciences of the United States of America, 106(33), 13820-13825. doi:10.1073/pnas.0905718106.
58. Harper, L. J., Costea, D. E., Gammon, L., Fazil, B., Biddle, A., & Mackenzie, I. C. (2010). Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance. BMC Cancer, 10, 166. doi:10.1186/1471-2407-10-166.
59. Surowiak, P., Materna, V., Kaplenko, I., Spaczynski, M., Dolinska- Krajewska, B., Gebarowska, E., et al. (2006). ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome. Clinical Cancer Research, 12(23), 7149-7158. doi:10.1158/1078-0432.CCR-06-0564. (Pubitemid 44974516)
60. Theile, D., Ketabi-Kiyanvash, N., Herold-Mende, C., Dyckhoff, G., Efferth, T., Bertholet, V., et al. (2011). Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma. Head & Neck, 33(7), 959-968. doi:10.1002/hed.21559.
61. Wang, X. Q., Ongkeko, W. M., Chen, L., Yang, Z. F., Lu, P., Chen, K. K., et al. (2010). Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKTATP- binding cassette G2 pathway. Hepatology, 52(2), 528-539. doi:10.1002/hep.23692.
62. Tsai, L. L., Yu, C. C., Chang, Y. C., Yu, C. H.,& Chou, M. Y. (2011). Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine. doi:10.1111/j.1600-0714.2011.01015.x.
63. Cheung, S. T., Cheung, P. F., Cheng, C. K.,Wong, N. C.,&Fan, S. T. (2011). Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance. Gastroenterology, 140(1), 344-355. doi:10.1053/j.gastro.2010.07.049.
64. Frank, N. Y., Margaryan, A., Huang, Y., Schatton, T., Waaga- Gasser, A. M., Gasser, M., et al. (2005). ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Research, 65(10), 4320-4333. doi:10.1158/ 0008-5472.CAN-04-3327.
65. Wei, J., Barr, J., Kong, L. Y., Wang, Y., Wu, A., Sharma, A. K., et al. (2010). Glioma-associated cancer-initiating cells induce immunosuppression. Clinical Cancer Research, 16(2), 461-473. doi:10.1158/1078-0432.CCR-09-1983.
66. Ramgolam, K., Lauriol, J., Lalou, C., Lauden, L., Michel, L., de la Grange, P., et al. (2011). Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function. PLoS One, 6(4), e18784. doi:10.1371/journal.pone. 0018784.
67. Quintana, E., Shackleton, M., Sabel, M. S., Fullen, D. R., Johnson, T. M., & Morrison, S. J. (2008). Efficient tumour formation by single human melanoma cells. Nature, 456(7222), 593-598. doi:10.1038/nature07567.
68. Pang, R., Law,W. L., Chu, A. C., Poon, J. T., Lam, C. S., Chow, A. K., et al. (2010). A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell, 6 (6), 603-615. doi:10.1016/j.stem.2010.04.001.
69. Marsh, D., Suchak, K., Moutasim, K. A., Vallath, S., Hopper, C., Jerjes, W., et al. (2011). Stromal features are predictive of disease mortality in oral cancer patients. The Journal of Pathology, 223(4), 470-481. doi:10.1002/path. 2830.